Primary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Schuster, Stephen J
  • Bishop, Michael R
  • Tam, Constantine S
  • Waller, Edmund K
  • Borchmann, Peter
  • McGuirk, Joseph P
  • Jaeger, Ulrich
  • Jaglowski, Samantha
  • Andreadis, Charalambos
  • Westin, Jason R
  • Fleury, Isabelle
  • Bachanova, Veronika
  • Foley, Ronan
  • Ho, P Joy
  • Mielke, Stephan
  • Magenau, John M
  • Holte, Harald
  • Van Besien, Koen
  • Kersten, Marie Jose
  • Teshima, Takanori
  • Tobinai, Kensei
  • Corradini, Paolo
  • Anak, Oezlem
  • Pacaud, Lida Bubuteishvili
  • del Corral, Christopher
  • Awasthi, Rakesh
  • Tai, Feng
  • Salles, Gilles
  • Maziarz, Richard Thomas

publication date

  • December 7, 2017

published in